Kallmeyer, JC, Seimon, LP & MacSearraigh, 1978 - Google Patents

The effect of thyrocalcitonin therapy and phosphate deprivation on tumoral calcinosis

Kallmeyer, JC, Seimon, LP & MacSearraigh, 1978

Document ID: 1621015301890829745
Author: Kallmeyer, JC, Seimon, LP & MacSearraigh E
Publication year: 1978
Publication venue: South African Medical Journal

External Links

Cited by

Snippet

The effect of thyrocalcitonin therapy and phosphate deprivation on tumoral calcinosis Page 1 2 December 1978 SA MEDICAL JOURNAL 963 The Effect of Thyrocalcitonin Therapy and Phosphate Deprivation on Tumoral Calcinosis JC KALLMEYER, L. P. SEIMON, ET …

Continue reading at journals.co.za (PDF) (other versions)

208000004434 Calcinosis 0 title abstract description 11

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication	Publication Date	Title
Lafferty et al.	1965	Tumoral calcinosis: a metabolic disease of obscure etiology
Faccini	1969	Fluoride and bone
Glover et al.	1994	Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose‐seeking study
Ellenberg et al.	1962	Thyroid carcinoma in patients with hyperparathyroidism
Neuman et al.	1957	Emerging concepts of the structure and metabolic functions of bone
Wilson	1989	Clinical and laboratory approaches for evaluation of nephrolithiasis
Ebisuno et al.	1986	Rice‐bran treatment for calcium stone formers with idiopathic hypercalciuria
Eckelman et al.	1974	99mTc-pyrophosphate for bone imaging
Reid et al.	1987	Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia: effect of successful tumor resection on mineral homeostasis
Kallmeyer, JC, Seimon, LP & MacSearraigh	1978	The effect of thyrocalcitonin therapy and phosphate deprivation on tumoral calcinosis
Pak et al.	1971	Effect of the oral administration of ammonium chloride, sodium phosphate, cellulose phosphate and parathyroid extract on the activity product of brushite in urine
Watson et al.	1977	Resolution of metastatic calcification revealed by bone scanning: case report
Desai et al.	1980	99mTc-MDP uptake in nonosseous lesions.
KAMMERMAN et al.	1970	Effect of porcine calcitonin on hypercalcemia in man
Mautalen et al.	1967	Pseudohypoparathyroidism 1942–1966: A negative progress report
Naik et al.	1976	Whole-body in-vivo neutron activation analysis in assessing treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.
Corstens et al.	1986	Resolution of massive technetium-99m methylene diphosphonate uptake in the stomach in vitamin D intoxication
Duarte et al.	1998	The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings
Heath et al.	1977	Pulmonary calcinosis.
Eisenberg et al.	1967	Hypophosphatasia in an Adult: A Case Report
Kramer et al.	1986	Destructive bone lesions in primary amyloidosis
Amico et al.	1986	Metastatic calcification in the thyroid gland demonstrated on bone scan in a patient with primary hyperparathyroidism
Johnson et al.	1971	The effect of subtotal parathyroidectomy and renal transplantation on mineral balance and secondary hyperparathyroidism in chronic renal failure
Boström et al.	1968	Case of chondrosarcoma with pulmonary and skeletal metastases after hemipelvectomy, successfully treated with 35S-sulfate
Oppenheim et al.	1989	Aluminum toxicity complicating renal osteodystrophy. A case report.